Should You Hold Medicinova Inc (MNOV) Stock Tuesday Morning?

Medicinova Inc (MNOV) is down Tuesday morning, with the stock losing -5.15% in pre-market trading to 1.29. MNOV's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 104 out of 146 industries, Medicinova Inc ranks higher than 6% of stocks. Medicinova Inc has fallen 9.33% over the past month, closing at $1.48 on January 23. During this period of time, the stock fell as low as $1.35 and as high as $1.53. MNOV has an average analyst recommendation of Strong Buy. The company has an average price target of $27.00.

MNOV has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on MNOV!

See Full MNOV Report

Medicinova Inc has a Long-Term Technical rank of 7. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 93% of the market scoring higher. In the Biotechnology industry which is number 67 by this metric, MNOV ranks better than 67% of stocks.

Important Dates for Investors in MNOV:

-Medicinova Inc is set to release earnings on 2024-05-15. Over the last 12 months, the company has reported EPS of $-0.19. -We do not have a set dividend date for Medicinova Inc at this time. Click Here To Get The Full Report on Medicinova Inc (MNOV)